A Long-term, Open-label Study Of Cp-690,550 to Confirm The Safety Following Long Term Administration Of Cp-690,550 In The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Study Of Cp-690,550 to Confirm The Safety Following Long Term Administration Of Cp-690,550 In The Treatment Of Rheumatoid Arthritis
The purpose of this study is to determine the long-term effectiveness and safety of CP-690,550 for the treatment of rheumatoid arthritis. Subjects are only eligible for this study after they have completed participation in another "qualifying" study of CP-690,550.
Inclusion Criteria:
Exclusion Criteria:
Yotukaidou, Chiba 284-0003, Japan
Iiduka, Fukuoka 820-8505, Japan
Sawara-ku, Fukuoka 814-0002, Japan
Hitachi-shi, Ibaraki 316-0035, Japan
Koushi, Kumamoto 861-1196, Japan
Ohmura, Nagasaki 856-0835, Japan
Kawagoe-shi, Saitama 350-8550, Japan
Arakawa-ku, Tokyo 116-8567, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
Bunkyo-ku, Tokyo 113-8519, Japan
Bunkyo-ku, Tokyo 113-8655, Japan
Chiyoda-ku, Tokyo 101-0062, Japan
Koto-ku, Tokyo 136-0075, Japan
Meguro-ku, Tokyo 152-8902, Japan
Musashimurayama-shi, Tokyo 208-0011, Japan
Setagaya-ku, Tokyo 155-0031, Japan
Shinjyuku-ku, Tokyo 162-0054, Japan